Tenax Therapeutics, Inc. (TENX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Tenax Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -9.09x | -5.37x | -0.71x | -0.30x | -0.66x | -1.40x |
| P/B Ratio | 4.92x | 1.03x | 0.67x | 2.19x | 5.04x | 2.98x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 14.56x | 20.60x | 3.26x | 1.74x | 3.64x | 3.21x |
| Quick Ratio | 14.56x | 20.60x | 3.26x | 1.74x | 3.64x | 3.21x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.06x | 0.54x | 0.07x | 0.07x |
YoY = year-over-year change. Source: FMP..